×
Back to Agenda
Patient Focus as Part of the Regulatory Affairs DNA: Opportunities and Challenges
Session Chair(s)
Max Wegner, PHARMD, RPH
Senior Vice President,Head Regulatory Affairs, Bayer, Germany
Patients are at the heart of everything we do. Integrating patient focus into the regulatory mindset can be a challenge. Panelists will discuss their experiences, share best practices, and describe challenges in achieving this goal.
Learning Objective : Identify best practices for integrating a patient focus mindset into the regulatory affairs organization; Recognize challenges faced by leaders in achieving this goal; Describe experiences with implementing patient focused practices as part of regulatory strategies.
Speaker(s)
FDA Perspective
Associate Center Director - CDER, FDA, United States
Patient Representative
Global Head of Patient Engagement and Advocacy, Novartis , Switzerland
Industry Perspective
Senior Regulatory Program Director, Genentech, A Member of the Roche Group, United States
Patient Representative
Corporate Relations Advisor, Rare Diseases International, France
Have an account?